Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018

  • ID: 4537883
  • Report
  • 201 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Biocad
  • Coherus BioSciences Inc
  • Genor BioPharma Co Ltd
  • Mycenax Biotech Inc
  • Pfizer Inc
  • MORE
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape.

Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

Report Highlights:

This latest pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 9, 6, 5, 13, 8 and 2 respectively.

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders).
  • The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders)
Reasons for Purchase:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Biocad
  • Coherus BioSciences Inc
  • Genor BioPharma Co Ltd
  • Mycenax Biotech Inc
  • Pfizer Inc
  • MORE
Introduction

Ankylosing Spondylitis (Bekhterev's Disease) - Overview

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment

Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development

Ankylosing Spondylitis (Bekhterev's Disease) - Drug Profiles

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects

Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products

Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018

Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018

Number of Products by Stage and Route of Administration, H1 2018

Number of Products by Stage and Molecule Type, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Adello Biologics LLC, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alteogen Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocad, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corp, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Eli Lilly and Co, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Fresenius SE & Co KGaA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Galapagos NV, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Immunwork Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Izana Bioscience Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nuevolution AB, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Pfizer Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by UCB SA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Biopharma AB, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018 (Contd..1), H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H1 2018

List of Figures

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Routes of Administration, H1 2018

Number of Products by Stage and Routes of Administration, H1 2018

Number of Products by Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc
  • Adello Biologics LLC
  • Alteogen Inc
  • Amgen Inc
  • Biocad
  • Biocon Ltd
  • Bionovis SA
  • Celgene Corp
  • Coherus BioSciences Inc
  • Eli Lilly and Co
  • Fresenius SE & Co KGaA
  • Galapagos NV
  • Genor BioPharma Co Ltd
  • Immunwork Inc
  • Innovent Biologics Inc
  • Izana Bioscience Ltd
  • Mycenax Biotech Inc
  • Nichi-Iko Pharmaceutical Co Ltd
  • Novartis AG
  • Nuevolution AB
  • Oncobiologics Inc
  • Pfizer Inc
  • Protalix BioTherapeutics Inc
  • Reliance Life Sciences Pvt Ltd
  • Sandoz International GmbH
  • Shanghai Pharmaceutical Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • UCB SA
  • Xbrane Biopharma AB
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll